Literature DB >> 10383734

Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice.

P J White1, R D Fogarty, I J Liepe, P M Delaney, G A Werther, C J Wraight.   

Abstract

Anti-sense oligonucleotide uptake by keratinocytes in human skin grafts on athymic mice was examined using live confocal microscopy. Fluorescein isothiocyanate-labeled 15-mer C-5 propyne modified phosphorothioate anti-sense oligonucleotide (10-50 microM) was intradermally injected into normal human skin grafts on athymic mice, and the localization of the anti-sense oligonucleotide was assessed after 1-24 h postinjection. Anti-sense oligonucleotide was found to localize in the nuclei of basal and suprabasal keratinocytes after 1-2 h, and this localization was still observed after 24 h. This live in vivo observation of anti-sense oligonucleotide uptake in basal keratinocytes was confirmed using conventional fluorescence microscopy of fixed sections of skin grafts. Neither single nucleotides which were fluorescein isothiocyanate-labeled nor fluorescein isothiocyanate alone was able to penetrate into the nuclei of human skin graft keratinocytes after intradermal injection, and hence it is likely that the anti-sense oligonucleotide was not degraded prior to intracellular localization. Topical administration of anti-sense oligonucleotide and anti-sense oligonucleotide-liposome complexes resulted primarily in localization in the stratum corneum of human skin grafts. When grafts were tape stripped prior to anti-sense oligonucleotide administration, however, as little as 5 microM anti-sense oligonucleotide was required to observe nuclear anti-sense oligonucleotide accumulation. These results suggest that cutaneous anti-sense strategies can be tested using delivery via intradermal anti-sense oligonucleotide injection in human skin grafts on athymic mice, and that agents providing penetration of anti-sense oligonucleotide across the stratum corneum are likely to be required for successful topical therapies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383734     DOI: 10.1046/j.1523-1747.1999.00593.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.

Authors:  W Lin; M Cormier; A Samiee; A Griffin; B Johnson; C L Teng; G E Hardee; P E Daddona
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

2.  Confocal fluorescence microscope with dual-axis architecture and biaxial postobjective scanning.

Authors:  Thomas D Wang; Christopher H Contag; Michael J Mandella; Ning Y Chan; Gordon S Kino
Journal:  J Biomed Opt       Date:  2004 Jul-Aug       Impact factor: 3.170

3.  Nanoparticles, molecular biosensors, and multispectral confocal microscopy.

Authors:  Tarl W Prow; Nicholas A Kotov; Yuri M Lvov; Rene Rijnbrand; James F Leary
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

4.  Comparative study of the skin penetration of protein transduction domains and a conjugated peptide.

Authors:  Luciana B Lopes; Colleen M Brophy; Elizabeth Furnish; Charles R Flynn; Olivia Sparks; Padmini Komalavilas; Lokesh Joshi; Alyssa Panitch; M Vitoria L B Bentley
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.